Press Releases
Empliciti (elotuzumab) for the Treatment of Multiple myeloma treatment...
First and only immunostimulatory antibody approved in the European Union for multiple myeloma Accelerated assessment and approval based on long-term data from ELOQUENT-2,...
Press Releases
EC approves Immuno-Oncology Combination, Bristol-Myers Squibbs Opdivo (nivolumab) +...
Opdivo + Yervoy Regimen now approved for unresectable or metastatic melanoma patients, regardless of BRAF mutational status Approval of the Regimen marks a...
Press Releases
Johnson & Johnson opens first international JLABs site in...
Johnson & Johnson Innovation LLC announced the opening of JLABS @ Toronto, a new 40,000-square-foot life sciences incubator, providing entrepreneurs shared lab space and offices,...
Press Releases
Merck Showcases New Innovations at Analytica 2016
Merck, a leading science and technology company, will exhibit a new range of products and solutions at Analytica 2016, the international trade fair for laboratory...
Press Releases
Baxter to Present at the 2016 UBS Global Healthcare...
Baxter International Inc will present at the 2016 UBS Global Healthcare Conference on Monday, May 23 in New York, NY. Jay Saccaro, corporate vice president...
Press Releases
US FDA Expands IMBRUVICA (ibrutinib) Label to Include Overall...
AbbVie a global biopharmaceutical company announced the U.S. Food and Drug Administration (FDA) updated the IMBRUVICA® (ibrutinib) Prescribing Information (PI) to include new data from...
Press Releases
Merck Launches First Commercially Available Equine-Specific Multiplex Assay for...
Merck, a leading science and technology company, today announced the global launch of the first commercially-available equine-specific multiplex assay for protein biomarkers. The assay is...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.